Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): A randomised controlled trial

The Lancet Infectious Diseases

Volumn 11, Issue 3, 2011, Pages 171-180

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; ZIDOVUDINE; LOPINAVIR; RITONAVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BURKINA FASO; CLINICAL PROTOCOL; COMBINATION CHEMOTHERAPY; DEVELOPING COUNTRY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREGNANCY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SINGLE DRUG DOSE; SOUTH AFRICA; SURVIVAL TIME; TREATMENT OUTCOME; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; ANEMIA; ANTIRETROVIRAL THERAPY; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; COMPARATIVE EFFECTIVENESS; CONGENITAL DISORDER; CONTROLLED STUDY; DRUG WITHDRAWAL; GASTROENTERITIS; INFECTION PREVENTION; MALARIA; MALNUTRITION; NEUTROPENIA; NEWBORN DISEASE; PNEUMONIA; POST TREATMENT SURVIVAL; PREGNANT WOMAN; RESPIRATORY TRACT INFECTION; TUBERCULOSIS; WASTING SYNDROME;

ADULT; AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; NEVIRAPINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; YOUNG ADULT; ZIDOVUDINE;

EID: 79952042500     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(10)70288-7     Document Type: Article

References (23)

1. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings WHO, (accessed June 23, 2010). http://www.who.int/hiv/pub/mtct/guidelinesarv/en/index.html.
2. HIV and infant feeding: update based on the technical consultation held on behalf of the Inter-agency Task Team (IATT) on prevention of HIV infection in pregnant women, mothers and their infants WHO, (accessed June 23, 2010). http://www.who.int/nutrition/publications/hivaids/9789241595964/en/index.html.
3. Tonwe-Gold B, Ekouevi DK, Viho I, et al. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in west Africa: evaluation of a two-tiered approach. PLoS Med 2007, 4:e257.
4. Thomas T, Masaba R, Ndivo R, et al. Prevention of MTCT of HIV-1 among breastfeeding mothers using HAART: the Kisumu Breastfeeding study, Kisumu, Kenya, 2003-2007. XV Conference on Retroviruses and Opportunistic Infections; Boston, USA; Feb 3-6, 2008. Abstract 45aLB.
5. Eighteen month follow-up of HIV-1 infected mothers and their children enrolled in the Kesho Bora Study observational cohorts. JAIDS 2010, 54:533-541. Kesho Bora Study Group.
6. Leroy V, Karon J, Alioum A, et al. Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa. AIDS 2002, 16:631-641.
7. Safety and effectiveness of antiretroviral drugs during pregnancy, delivery and breastfeeding for prevention of mother-to-child transmission of HIV-1: the Kesho Bora multicentre collaborative study rationale, design, and implementation challenges. Contemp Clin Trials 2011, 32:74-85. Kesho Bora Study Group.
8. Gaillard P, Fowler MG, Dabis F, et al. Use of antiretroviral drugs to prevent HIV-1 transmission through breastfeeding: from animal studies to randomized clinical trials. J Acquir Immune Defic Syndr 2004, 35:178-187.
9. Chasela C, Hudgens M, Jamieson D, et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 2010, 362:2271-2281.
10. Shapiro R, Hughes M, Ogwu A, et al. Antiretroviral regimens in pregnancy and breastfeeding in Botswana. N Engl J Med 2010, 362:2282-2294.
11. Division of AIDS tables for grading severity of adult adverse experiences DAIDS/NIAID/NIH, (accessed June 23, 2010). http://rsc.tech-res.com/Document/safetyandpharmacovigilance/Table_for_Grading_Severity_of_Adult_AEs_v01a.pdf.
12. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access: recommendations for a public health approach WHO, (accessed June 23, 2010). http://www.who.int/hiv/pub/mtct/antiretroviral/en/index.html.
13. HIV and infant feeding: a guide for health care managers and supervisors WHO, (accessed June 23, 2010). http://www.who.int/nutrition/publications/hivaids/9241591234/en/index.html.
14. Gaillard P, Piwoz E, Farley TM Collection of standardized information on infant feeding in the context of mother-to-child transmission of HIV. Stat Med 2001, 20:3525-3537.
15. Rouet F, Foulongne V, Viljoen J, et al. Comparison of the generic HIV viral load assay with the amplicor HIV-1 monitor v1.5 and nuclisens HIV-1 easyQ v1.2 techniques for plasma HIV-1 RNA quantification of non-B subtypes: the Kesho Bora preparatory study. J Virol Methods 2010, 163:253-257.
16. Alioum A, Cortina-Borja M, Dabis F, et al. Estimating the efficacy of interventions to prevent mother-to-child transmission of human immunodeficiency virus in breastfeeding populations: comparing statistical methods. Am J Epidemiol 2003, 158:596-605.
17. The global burden of disease: 2004 update WHO, (accessed May 24, 2010). http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/print.html.
18. Peltier CA, Ndayisaba GF, Lepage P, et al. Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent HIV postnatal mother-to-child transmission in Rwanda. AIDS 2009, 23:2415-2423.
19. Marazzi MC, Nielsen-Saines K, Buonomo E, et al. Increased infant HIV-1 free survival at one year of age in sub-Saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding. Pediatr Infect Dis J 2009, 28:483-487.
20. Kilewo C, Karlsson K, Ngarina M, et al. Prevention of MTCT of HIV-1 through breastfeeding by treating infants or mothers prophylactically with antiretrovirals in Dar es Salaam, Tanzania: the MITRA and MITRA+ studies. Retrovirology 2008, 5(suppl I):O17.
21. Kesho Bora Study Group. Triple-antiretroviral prophylaxis during pregnancy and breastfeeding compared to zidovudine/single-dose nevirapine prophylaxis to prevent MTCT: the Kesho Bora randomized controlled clinical trial in five sites in Burkina Faso, Kenya and South Africa. 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention; Cape Town, South Africa; July 19-22, 2009. Abstract LBPEC01.
22. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach WHO, (accessed Jan 6, 2011). http://whqlibdoc.who.int/publications/2010/9789241599818_eng.pdf.
23. Kumwenda NI, Hoover DR, Mofenson LM, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 2008, 359:119-129.